Breaking News, Financial News

Financial Report: ICON 4Q

Operating income was $92 million for the year, representing 10.2% of revenue.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

ICON 4Q 4Q Revenues: $232.1 million (+2%) 4Q Earnings: $22.1 million (-8%) FY Revenues: $900.0 million (+1%) FY Earnings: $87.1 million (-5%) Comments: Operating income was $92 million for the year, representing 10.2% of revenue. This comprised clinical services operating income of $104.8 million or 12.5%, and central lab operating losses of $12.8 million. In the quarter, operating income was $22 million, representing 9.5% of revenue. Clinical services operating income accounted f...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters